PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$37.67 USD
-0.02 (-0.05%)
Updated Jun 12, 2024 04:00 PM ET
After-Market: $37.69 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Brokerage Reports
PTC Therapeutics, Inc. [PTCT]
Reports for Purchase
Showing records 121 - 140 ( 147 total )
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Negative Conditional Approval Opinion Lifts Overhang
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Negative Conditional Approval Opinion Lifts Overhang - Buy on Weakness: PIII Trial Enriched for Success - Reiterate OUTPERFORM and $55 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
SMA Trial Start Ahead of Schedule Triggers $7.5M Milestone
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Beyond Ataluren: SMA Trial Start Ahead of Schedule Triggers $7.5M Milestone
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Jan. 20
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
2014 Update - SMA into the Clinic and New Indications for Ataluren Offer Significant Catalysts in the Year Ahead - Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Jan. 20
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
2014 Update - SMA into the Clinic and New Indications for Ataluren Offer Significant Catalysts in the Year Ahead - Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Jan. 13
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Q3 Update - 2014 a Value-Creating Year for PTCT - SMA Program Updates and Next Indication for Ataluren - Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
An Appropriately Powered Study in DMD Is Only the Beginning - Looking for SMA Update and Ataluren''s Next Indication in 2014 - Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
An Appropriately Powered Study in DMD Is Only the Beginning
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Analyst Day Highlights: Ataluren''s Next Indication to be Determined in 2014, SMA Updates to Come in 2014 - Broad Pipeline Undervalued
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Oct. 28
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Oct. 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Sell-off Unfounded - PTCT Is an Undervalued and Misunderstood Low-Risk Name with Catalysts Ahead - Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals/BioDefense - WMS Day 1 and KOL Dinner with Dr. McDonald and Friends - The Path Forward in DMD
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals/BioDefense - KOL Dinner with Dr. Craig McDonald, Oct 2 - Looking Ahead to World Muscle
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: PTC Therapeutics, Inc.
Industry: Medical - Drugs
Drisapersen Results Highlight Ataluren''s Clinically Meaningful Benefit
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C